Results 251 to 260 of about 79,005 (262)

Preparation and drug release property of tanshinone IIA loaded chitosan-montmorillonite microspheres

International Journal of Biological Macromolecules, 2019
Guo-Hua Li
exaly  

Tanshinone IIA inhibits β-catenin/VEGF-mediated angiogenesis by targeting TGF-β1 in normoxic and HIF-1α in hypoxic microenvironments in human colorectal cancer

Cancer Letters, 2017
Lihong Zhou, Chunpu Li, Qing Ji
exaly  

Protective effects of cationic bovine serum albumin-conjugated PEGylated tanshinone IIA nanoparticles on cerebral ischemia

Biomaterials, 2013
Xin Liu
exaly  

Effects of the combination of tanshinone IIA and puerarin on cardiac function and inflammatory response in myocardial ischemia mice

Journal of Molecular and Cellular Cardiology, 2019
Jingyu Ni, Guanwei Fan
exaly  

Pharmacokinetics and atherosclerotic lesions targeting effects of tanshinone IIA discoidal and spherical biomimetic high density lipoproteins

Biomaterials, 2013
Wenli Zhang, Hongliang He, Jianping Liu
exaly  

Activation of p53 Signaling and Inhibition of Androgen Receptor Mediate Tanshinone IIA Induced G1 Arrest in LNCaP Prostate Cancer Cells

Phytotherapy Research, 2012
Junxuan Lü, Sung-Hoon Kim
exaly  

Tanshinone IIA isolated from Salvia miltiorrhiza elicits the cell death of human endothelial cells

Journal of Biomedical Science, 2005
Chung-Jiuan Jeng, Hsiu-Ni Kung, Yat-Pang Chau   +2 more
exaly  

Tanshinone IIA stimulates erythrocyte phosphatidylserine exposure

2011
Rosaclerio L., Tripodi P. M., Zelenak C., Qadri S. M., Jilani K., FAGGIO, Caterina, Lang F.   +6 more
openaire   +1 more source

Tanshinone IIA prevents the loss of nigrostriatal dopaminergic neurons by inhibiting NADPH oxidase and iNOS in the MPTP model of Parkinson's disease

Journal of the Neurological Sciences, 2015
Bo Ren
exaly  

PROTECTIVE EFFECTS OF SODIUM TANSHINONE IIA SULPHONATE AGAINST ADRIAMYCIN-INDUCED LIPID PEROXIDATION IN MICE HEARTSIN VIVO AND IN VITRO

Pharmacological Research, 1999
exaly